grant

A novel dual therapy approach to treatment of multidrug-resistant Gram-negative infections

Also known as: Ideas Grants

Funded by National Health and Medical Research Council
Managed by University of Adelaide
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/2020758]

Funding Amount $981,046.50

Full description This project will use multiple advanced approaches to pinpoint how new derivatives of the anticoccidial drug robenidine kill and exert their specific activities against different superbugs. This study is of utmost significance in the current era of inexorable rise in multidrug resistance. The project will generate critical data that will promote targeted and responsible use of new antimicrobials, in alignment with similar global approaches towards eliminating multidrug resistance development.

Chief Investigator Dr Abiodun Ogunniyi

Date Announced 2022-12-14T00:00:00

Sector University

Click to explore relationships graph
Help

Related Organisations

Spatial Coverage And Location

text: SA

Subjects
Biological Sciences | Bacteriology | Basic Science Research | Infectious Agents | Medical and Health Sciences | Medical Microbiology | Microbiology | Medical Bacteriology | bacterial infection | biomedical and clinical sciences | medical bacteriology | molecular imaging | mouse models | multidrug resistance |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA